![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1567215
¾ÆÆ÷Åä½Ã½º ½ÃÀå : ¿ëµµº°, ¸ð´Þ¸®Æ¼º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°Apoptosis Market, By Application, By Modality, By End User, By Geography |
¾ÆÆ÷Åä½Ã½º ¼¼°è ½ÃÀåÀº 2024³â 38¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 56¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 5.8%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§ | º¸°í¼ »ó¼¼ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2023³â | 2024³â ½ÃÀå ±Ô¸ð | 38¾ï 1,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£ 2024-2031³â CAGR: | 5.80% | 2031³â °¡Ä¡ ¿¹Ãø | 56¾ï 5,000¸¸ ´Þ·¯ |
ÀϹÝÀûÀ¸·Î ÇÁ·Î±×·¥µÈ ¼¼Æ÷ »ç¸ê·Î ¾Ë·ÁÁø ¾ÆÆ÷Åä½Ã½º´Â ¿øÄ¡ ¾Ê´Â ¼¼Æ÷³ª ¼Õ»óµÈ ¼¼Æ÷¸¦ ÅëÁ¦µÈ ¹æ½ÄÀ¸·Î Á¦°ÅÇÏ´Â »ý¹°Ã¼ÀÇ ÀÚ¿¬Àû °úÁ¤ÀÔ´Ï´Ù. ¾ÆÆ÷Åä½Ã½ºÀÇ Á¶Àý Àå¾Ö´Â ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, ½Å°æÅðÇ༺ Áúȯ°ú °°Àº º´Àû »óŸ¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ ÀÌ·¯ÇÑ ÁúȯÀÇ Ä¡·á¸¦ À§ÇØ ¾ÆÆ÷Åä½Ã½ºÀ» Á¶ÀýÇÏ´Â »õ·Î¿î Ç¥Àû Ä¡·áÁ¦ÀÇ ¿¬±¸ °³¹ßÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾ÆÆ÷Åä½Ã½ºÀÇ ºÐÀÚÀû ±âÀüÀÌ ¹àÇôÁö°í »õ·Î¿î °æ·Î ¾ïÁ¦Á¦°¡ °³¹ßµÊ¿¡ µû¶ó ±× ¿ëµµ°¡ È®´ëµÇ¸é¼ Àü ¼¼°èÀûÀ¸·Î ¾ÆÆ÷Åä½Ã½º Á¶Àý ¾à¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¾Ï ¹× ±âŸ ¾ÆÆ÷Åä½Ã½º °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¦¾àȸ»çÀÇ R&D ÅõÀÚ Áõ°¡, ½Å±Ô Ç¥Àû ¾ÆÆ÷Åä½Ã½º Á¶Àý ¾à¹°¿¡ ´ëÇÑ USFDA ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ¿¬°£ 70% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¾à¹° °³¹ß ¹× ÀÓ»ó½ÃÇè¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±àÁ¤ÀûÀÎ Ãø¸éÀ¸·Î, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀåÀº ÀÌ Áö¿ªÀÇ ÀÇ·áºñ Áõ°¡¿Í ¾çÁúÀÇ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ½ÃÀå Ç÷¹À̾°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´¿ë¿ä¹ý ¹× ÆÄÀÌÇÁ¶óÀÎ ÀǾàǰ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È »õ·Î¿î Àü¸ÁÀÌ °è¼Ó âÃâµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¦°øÇÏ´Â ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼® º¸°í¼ÀÔ´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.
±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott, Roche, Novartis, Bristol-Myers Squibb, Merck, Pfizer µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¾ÆÆ÷Åä½Ã½º ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
The Global Apoptosis Market is estimated to be valued at USD 3.81 Billion in 2024 and is expected to reach USD 5.65 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 3.81 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 5.80% | 2031 Value Projection: | US$ 5.65 Bn |
Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, research and development of new targeted therapeutics to modulate apoptosis for treatment of such diseases is contributing to the growth of this market. Advancements in understanding the molecular mechanisms of apoptosis and development of novel pathway inhibitors are expanding the applications and driving the demand for apoptosis modulating drugs globally.
Rise in prevalence of cancer and other apoptosis related disorders, increasing R&D investments by pharmaceutical companies, and growing USFDA approvals for novel targeted apoptosis modulating drugs are some of the major factors projected to propel the global apoptosis market during the forecast period. According to WHO, cancer burden is expected to grow by 70% in the next two decades. However, high costs associated with drug development and clinical trials may hamper market growth. On the positive side, emerging markets such as Asia Pacific and Latin America offer lucrative opportunities for market players due to growing healthcare expenditure and demand for quality care in these regions. Furthermore, ongoing research on combination therapies and pipeline drugs will continue creating new prospects over the coming years.
This report provides in-depth analysis of the global apoptosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global apoptosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbot, Roche, Novartis, Bristol-Myers Squibb, Merck, and Pfizer
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global apoptosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apoptosis market.
Detailed Segmentation-